Recognition of HLA class I–restricted β-cell epitopes in type 1 diabetes

Q Ouyang, NE Standifer, H Qin, P Gottlieb… - Diabetes, 2006 - Am Diabetes Assoc
Q Ouyang, NE Standifer, H Qin, P Gottlieb, CB Verchere, GT Nepom, R Tan
Diabetes, 2006Am Diabetes Assoc
Type 1 diabetes results from the autoimmune destruction of insulin-producing pancreatic β-
cells by cytotoxic T-lymphocytes (CTLs). In humans, few β-cell epitopes have been reported,
thereby limiting the study of β-cell–specific CTLs in type 1 diabetes. To identify additional
epitopes, HLA class I peptide affinity algorithms were used to identify a panel of peptides
derived from the β-cell proteins islet amyloid polypeptide (IAPP), islet-specific glucose-6-
phosphatase catalytic subunit–related protein (IGRP), insulin, insulinoma-associated …
Type 1 diabetes results from the autoimmune destruction of insulin-producing pancreatic β-cells by cytotoxic T-lymphocytes (CTLs). In humans, few β-cell epitopes have been reported, thereby limiting the study of β-cell–specific CTLs in type 1 diabetes. To identify additional epitopes, HLA class I peptide affinity algorithms were used to identify a panel of peptides derived from the β-cell proteins islet amyloid polypeptide (IAPP), islet-specific glucose-6-phosphatase catalytic subunit–related protein (IGRP), insulin, insulinoma-associated antigen 2 (IA-2), and phogrin that were predicted to bind HLA-A*0201. Peripheral blood mononuclear cells from 24 HLA-A*0201 recent-onset type 1 diabetic patients and 11 nondiabetic control subjects were evaluated for γ-interferon secretion in response to peptide stimulation in enzyme-linked immunospot assays. We identified peptides IAPP9-17, IGRP215-223, IGRP152-160, islet IA-2(172-180), and IA-2(482-490) as novel HLA-A*0201–restricted T-cell epitopes in type 1 diabetic patients. Interestingly, we observed a strong inverse correlation between the binding affinity of β-cell peptides to HLA-A*0201 and CTL responses against those peptides in recent-onset type 1 diabetic patients. In addition, we found that self-reactive CTLs with specificity for an insulin peptide are frequently present in healthy individuals. These data suggest that many β-cell epitopes are recognized by CTLs in recent-onset type 1 diabetic patients. These epitopes may be important in the pathogenesis of type 1 diabetes.
Am Diabetes Assoc